Abstract A102: First‐in‐man, first‐in‐class, pharmacokinetic and pharmacodynamic phase I clinical trial of a human monoclonal antibody CNTO888 to CC‐chemokine ligand 2 (CCL2) / monocyte chemoattractant protein (MCP‐1) in patients with advanced solid tumors
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2548-2548
◽
2012 ◽
Vol 31
(3)
◽
pp. 760-768
◽
2010 ◽
Vol 399
(4)
◽
pp. 677-682
◽
2012 ◽
Vol 53
(10)
◽
pp. 6702
◽
2010 ◽
Vol 184
(8)
◽
pp. 4479-4487
◽
2005 ◽
Vol 175
(12)
◽
pp. 8346-8353
◽
2007 ◽
Vol 179
(12)
◽
pp. 8500-8508
◽